These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 23251685)

  • 1. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
    Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
    PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput sequencing reveals restricted TCR Vβ usage and public TCRβ clonotypes among pancreatic lymph node memory CD4(+) T cells and their involvement in autoimmune diabetes.
    Marrero I; Aguilera C; Hamm DE; Quinn A; Kumar V
    Mol Immunol; 2016 Jun; 74():82-95. PubMed ID: 27161799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
    Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
    J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet-associated T-cell receptor-β CDR sequence repertoire in prediabetic NOD mice reveals antigen-driven T-cell expansion and shared usage of VβJβ TCR chains.
    Toivonen R; Arstila TP; Hänninen A
    Mol Immunol; 2015 Mar; 64(1):127-35. PubMed ID: 25480393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectratyping analysis of the islet-reactive T cell repertoire in diabetic NOD Igμ(null) mice after polyclonal B cell reconstitution.
    Vong AM; Daneshjou N; Norori PY; Sheng H; Braciak TA; Sercarz EE; Gabaglia CR
    J Transl Med; 2011 Jul; 9():101. PubMed ID: 21722394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct.
    Young EF; Hess PR; Arnold LW; Tisch R; Frelinger JA
    Autoimmunity; 2009; 42(8):678-91. PubMed ID: 19886740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.
    Verdaguer J; Schmidt D; Amrani A; Anderson B; Averill N; Santamaria P
    J Exp Med; 1997 Nov; 186(10):1663-76. PubMed ID: 9362527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peri-islet infiltrates of young non-obese diabetic mice display restricted TCR beta-chain diversity.
    Galley KA; Danska JS
    J Immunol; 1995 Mar; 154(6):2969-82. PubMed ID: 7533189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid destruction of encapsulated islet xenografts by NOD mice is CD4-dependent and facilitated by B-cells: innate immunity and autoimmunity do not play significant roles.
    Xu BY; Yang H; Serreze DV; MacIntosh R; Yu W; Wright JR
    Transplantation; 2005 Aug; 80(3):402-9. PubMed ID: 16082337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
    Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
    Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
    Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
    Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.
    Ashkenazi E; Baranovski BM; Shahaf G; Lewis EC
    PLoS One; 2013; 8(5):e63625. PubMed ID: 23717456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets.
    Van Belle TL; Nierkens S; Arens R; von Herrath MG
    Immunity; 2012 Jun; 36(6):1060-72. PubMed ID: 22579473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
    J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local autoantigen expression as essential gatekeeper of memory T-cell recruitment to islet grafts in diabetic hosts.
    Alkemade GM; Clemente-Casares X; Yu Z; Xu BY; Wang J; Tsai S; Wright JR; Roep BO; Santamaria P
    Diabetes; 2013 Mar; 62(3):905-11. PubMed ID: 23160528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.